Skip to main navigation Skip to search Skip to main content

Penicillin V twice daily vs. Four times daily in the treatment of streptococcal pharyngitis

  • R. Raz
  • , G. Elchanan
  • , R. Colodner
  • , S. Reiss
  • , P. Schvartzman
  • , H. Tabenkin
  • , Y. Leshem
  • Emek Medical Center
  • Departments of Family Medicine
  • Ben-Gurion University of the Negev

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Treatment failure of streptococcal pharyngitis with oral penicillin might be due to patient noncompliance. We performed a randomized controlled study of 104 patients with group A ß-hemolytic streptococcal pharyngitis; 51 patients received penicillin V 1 g twice daily and 53 patients, 500 mg four times a day for 10 days. At day 9-10 of treatment, the number of patients free of symptoms was significantly greater in the twice-daily than in the four-times-daily group (92% vs. 77%); similarly, the number of patients with sterile throat cultures was significantly greater in the twice-daily group (90% vs. 73%). Differences in clinical and bactériologie responses were still significant 28 days posttherapy. Compliance was 90% in the twice-daily group vs. 58%. Penicillin V given twice daily is more effective than a four-times-daily regimen in the treatment of streptococcal pharyngitis, probably because patient compliance is improved.

Original languageEnglish
Pages (from-to)50-54
Number of pages5
JournalInfectious Diseases in Clinical Practice
Volume4
Issue number1
DOIs
StatePublished - Jan 1995
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Penicillin V twice daily vs. Four times daily in the treatment of streptococcal pharyngitis'. Together they form a unique fingerprint.

Cite this